A new study suggests a potential molecular strategy for treating fragile X syndrome, an inherited neurodevelopmental disorder that causes autism…

The Cancer Prevention and Research Institute of Texas (CPRIT) awarded the University of Texas MD Anderson Cancer Center nearly $23…

Researchers at the European Molecular Biology Laboratory (EMBL) say they have made an important leap forward with a novel methodology…

Atomic force microscopy images show hepatitis B DNA in its natural state (left) and a zoomed-in look at how it…

Evan Feinberg, PhD, founder and CEO of Genesis Therapeutics Incyte will partner with Genesis Therapeutics to research, discover, and develop…

Atrandi Biosciences has raised $25 million in a Series A funding round led by Lux Capital, with participation from Vsquared…

Panelists:Broadcast Date:  Tuesday, March 18, 2025Time:  8:00 am PT, 11:00 am ET, 16:00 CETMethylation analysis holds significant promise for clinical…

The U.K.’s advanced therapy sector is increasing its capability to manufacture at the commercial scale. That’s according to Alice Brown,…

Producing the best biotherapeutics depends increasingly on the use of sensors to track the process. One way to do that…